#USA #Stamford #Biogen #Better Together #Lupus Warrior

Proximity Health Solutions and Biogen: A Transformative Partnership

In an exciting development for patient engagement in clinical trials, Proximity Health Solutions, in partnership with Biogen, has announced that their initiative, Better Together: Sharing Our Lupus Stories, is among the finalists for the revered 2026 SCOPE Participant Engagement Award. This recognition highlights their commitment to advancing the understanding and participation of patients in clinical trials, particularly focusing on female, African American lupus patients.

The Better Together Initiative

The Better Together webinar series, designed to educate and empower lupus patients, has made remarkable strides in enhancing patient engagement. Now in its fifth season, the series is aired on BlackDoctor.Org's Facebook Live, where it has amassed an impressive one million views across episodes, averaging 47,000 views per episode. These figures not only reflect the sustainability and scalability of the initiative but also underscore its significant impact on the community.

Rick Adler, CEO of Proximity Health Solutions, expressed his gratitude for the recognition, stating, “We are honored that the Better Together webinar series has been recognized as a finalist for the SCOPE '26 Participant Engagement Award. This recognition reconfirms our mission to educate patients, enabling them to make informed decisions about their medical care and their decision to participate in a clinical trial.”

Recognizing Patient-Centric Approaches

The SCOPE Participant Engagement Award acknowledges innovative programs aimed at enhancing patient understanding and involvement in clinical research. The Better Together initiative stands out for its thoughtful design and measurable impact, particularly in educating lupus patients about their condition and the importance of clinical trial participation.

Tara Aldoory, Head of Quantitative Sciences and Development Operations at Biogen, noted, “The Better Together series has enabled Biogen to integrate patient perspectives, creating an empathetic, educational, and engaging community, positioning Biogen as a trusted resource for lupus patients.” She further stressed the value of recognizing the lupus patients as “Lupus Warriors,” who inspire and drive the mission of educating others.

This collaboration illustrates how patient-centered initiatives can effectively foster understanding and trust within the medical community, redefining engagement strategies for clinical trials. By addressing the unique needs of underrepresented patient populations, both Proximity Health Solutions and Biogen are paving the way for more inclusive healthcare practices.

A Commitment to the Future

With the SCOPE '26 Participant Engagement Award winners set to be announced at the upcoming Summit for Clinical Ops Executives in February 2026, the anticipation surrounding this recognition underlines the importance of responsible and patient-focused practices in clinical research. Both Proximity Health Solutions and Biogen remain focused on their mission to improve health outcomes for underrepresented populations and foster impactful educational programs.

For more information about Proximity Health Solutions and their initiatives, visit their official website at www.proximityhealthsolutions.com. By continuing to shed light on critical issues facing patients today, they are not just competing for awards; they are championing a cause that holds transformative potential for many individuals living with lupus.